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816-1 Screening Stress Myocardial Perfusion Imaging for Risk 
Stratification in Asymptomatic Diabetic Men
Brian G. Abbott, James A. Arrighi, Yale University School of Medicine, New Haven, CT, 
VA Connecticut Healthcare System, West Haven, CT
Background: The utility of screening asymptomatic diabetic patients for coronary artery
disease (CAD) has not been defined. The objective of the current study was to evaluate
the impact of a strategy employing screening stress myocardial perfusion imaging (MPI)
on short-term prognosis in diabetic patients without symptoms or known CAD, who other-
wise had no indication for stress MPI. Methods: Asymptomatic diabetic males were
enrolled in a strategy of screening stress MPI. All patients underwent routine MPI after
exercise or dipyridamole stress using standard protocols, and were followed clinically for
cardiac events (cardiac death, myocardial infarction, coronary angiography and revascu-
larization). The Framingham global risk assessment score was used to for comparison of
risk factors and to estimate the pre-test likelihood of CAD among patients. Results: In 44
asymptomatic diabetic males (age 66±8 years) without known CAD, 20 (45%) had an
abnormal stress MPI (9 mildly abnormal, 11 moderately/severely abnormal). During
short-term follow-up (18+3 months), there were no major adverse cardiac events in 33
patients with a normal or mildly abnormal stress MPI. Of 11 patients with a moderately/
severely abnormal MPI, 7 were subsequently referred for coronary angiography. All 7 had
significant CAD (6 with left main coronary artery and/or 3-vessel CAD), and 5 of these
patients required revascularization (4 surgical). The Framingham global risk profile score
for CAD in patients with a normal/ mildly abnormal MPI was similar to those with a mod-
erate/severely abnormal stress MPI (9.7±2.6 vs. 9.8±2.2, respectively, p=NS). Conclu-
sion: A strategy of screening asymptomatic diabetics for CAD with stress MPI may be
justified for additional risk stratification beyond clinical assessment. Patients with a nor-
mal or mildly abnormal stress MPI have a favorable prognosis, while those with a moder-
ately/severely abnormal study (25% in this population) have a high incidence of severe
CAD that may warrant assessment with angiography.
2:15 p.m.
816-2 Risk Stratification of Diabetic Patients With Rest/Stress 
ECG-Gated Tc-99m Sestamibi SPECT Imaging: 
Significance of Mild Perfusion Abnormalities
Sachin M. Navare, Gavin L. Noble, Safi U. Ahmed, Alan W. Ahlberg, Deborah M. Katten, 
Lori L. Alexander, Leslee J. Shaw, William E. Boden, Gary V. Heller, Hartford Hospital, 
Hartford, CT
Background
Diabetic patients have a higher risk for future cardiac events than comparable non-dia-
betic patients. However, there are limited data comparing severity of perfusion abnormal-
ities between diabetic and non-diabetic patients.
Methods
Consecutive patients referred for rest/stress Tc-99m sestamibi ECG-gated SPECT imag-
ing were followed (29 ± 17 months) prospectively for cardiac events (cardiac death or
myocardial infarction). Perfusion images were classified as normal [summed stress
scores (SSS) = 0-2}], mildly abnormal [SSS = 3-5] and moderate/severely abnormal
[SSS >5] by an 8-segment model. Of 8142 patients, 1865 were diabetics (23 %).
Results
Patients with diabetes had significantly higher annual cardiac event rates with both nor-
mal (2.6 % vs. 1.3 %, p<0.01) and abnormal (9.5 % vs. 4.9 %, p< 0.01) perfusion images
as compared to patients without diabetes. In non-diabetic patients, cardiac event free
survival correlated with the severity of perfusion abnormality. In diabetic patients, even
mild perfusion abnormality was associated with significantly lower event free survival.
However, assessment of LV function by gated-SPECT aided further risk stratification of
this subgroup. Patients with mild defects and normal function had an intermediate prog-
nosis while those with impaired function had worse prognosis.
Conclusion
Diabetic patients with mild perfusion abnormalities have a worse prognosis than non-dia-
betic patients. This may have implications for therapeutic approaches.
2:30 p.m.
816-3 Interaction of Age and Gender on Risk Stratification of 
Diabetic Patients With Rest/Stress ECG-Gated Tc-99m 
Sestamibi SPECT Imaging
Sachin M. Navare, Safi U. Ahmed, Gavin L. Noble, Alan W. Ahlberg, Deborah M. Katten, 
Giselle Cyr, Leslee J. Shaw, William E. Boden, Gary V. Heller, Hartford Hospital, Hartford, 
CT
Background
Diabetes is a powerful risk factor for CAD, particularly in women. However, there are lim-
ited data on the interaction of age, gender and diabetic status on risk stratification using
myocardial perfusion imaging.
Methods
Consecutive patients referred for rest/stress Tc-99m sestamibi ECG-gated SPECT imag-
ing were followed prospectively (29 ± 17 months) for cardiac events (cardiac death or
myocardial infarction). Perfusion images were classified as normal [summed stress
scores (SSS) < 3}] or abnormal [SSS > 3] by an 8-segment model. Of 1865 diabetic
patients, 884 (47%) were men and 981 (53%) were women.
Results
Annual cardiac event rates were significantly lower in women as compared with men (2.9
% vs. 4.8 %, p < 0.01). Cardiac event rates increased significantly with age (>55 years) in
women (1.2 % vs. 3.6 %, p < 0.01), not in men (3.7 % vs. 5.2 %, p = ns). Risk stratifica-
tion with perfusion imaging demonstrated that women > 55 years had outcomes similar to
non-diabetic patients (p = ns). Normal perfusion in older women was associated with low
risk (p = ns compared to younger women), while abnormal imaging was associated with
the highest risk (comparable to diabetic men, p = ns). However, men with normal perfu-
sion had intermediate risk, irrespective of age.
Conclusion
Increasing age has a significant impact on prognosis of diabetic women, but not men.
Although the risk of cardiac events in older women increased significantly, myocardial
perfusion imaging is effective in risk stratifying women diabetics.
2:45 p.m.
816-4 Effect of Glucose Lowering on Coronary Circulatory 
Dysfunction in Type 2 Diabetes Mellitus
Alvaro D. Facta, John O. Prior, Thomas H. Schindler, Jerson Cadenas, Manuel J. 
Quinones, Willa A. Hsueh, Heinrich R. Schelbert, David Geffen School of Medicine at 
UCLA, Los Angeles, CA
Objective: To determine the effect of plasma glucose lowering on coronary circulatory
function in patients with type 2 diabetes.
Methods: In sixteen type 2 diabetic patients (age 55±6 years old) with elevated fasting
glucose plasma levels myocardial blood flow (MBF) was measured with 13N-ammonia
and PET at rest, during cold pressor testing (CPT) and during adenosine hyperemia; at
baseline and after 12 weeks of glucose-lowering therapy with Glyburide and Metformin.
MBF response to adenosine represented the total vasodilator capacity and to CPT the
flow-mediated (endothelial-dependent) vasomotion.
Results: In eleven patients, plasma glucose decreased from 206±89 to 109±15 mg/dl
(p<0.01) over the follow-up period (Group 1), while in 5 patients remain elevated 241±33
and 211±35 mg/dl (p=NS; Group 2).
In Group 2, MBF at rest was 0.69±0.19 ml/g/min at baseline and 0.65±0.22 ml/g/min dur-
ing the follow up (p=NS). Adenosine hyperemic MBF was at baseline 1.38±0.11 ml/g/min
and 1.64±0.37 ml/g/min at follow-up (p=NS). During CPT, the rate pressor product (RPP)
increased by 38±12% at baseline and 36±11% at follow-up (p=NS), and MBF by only
15±22% and 22±10% at baseline and follow-up, respectively (p=NS).
In the Group 1 patients, MBF at rest was 0.78±0.24 ml/g/min at baseline and 0.67±0.12
ml/g/min at follow-up (p=NS) and these were similar to Group 2. Hyperemic MBF was
1.85±0.30 ml/g/min at baseline and did no increase significantly at follow-up, 2.05±0.51
ml/g/min (p=NS). Importantly, for RPP increases of 21±13 and 28±16% (p=NS) by CPT,
the MBF significantly increased from 10±11% at baseline to 33±18% at follow-up
(p<0.01). Moreover, the percent of improvement in the MBF response to CPT from base-
line to follow-up was significantly correlated with the percent decrease in plasma glucose












Conclusion: This finding suggests that glucose-lowering treatment in type 2 diabetes
beneficially influences the coronary circulatory function. The significant increase of MBF
responses to CPT may be related to the extent of lowered glucose plasma levels. This
improvement may result directly from lowering plasma glucose levels and/or antidiabetic
agents.
3:00 p.m.
816-5 Progression of Coronary Artery Disesase in Diabetics 
Demonstrated by Single Isotope Rest/Stress Tc-99m 
Sestamibi Myocardial Perfusion Imaging: More Rapid 
Than Nondiabetics?
Gavin L. Noble, Sachin M. Navare, Syed A. Hussain, Deborah M. Katten, Alan W. 
Ahlberg, Jacob Calvert, William E. Boden, Gary V. Heller, Hartford Hospital, Hartford, CT
Background: Patients with Diabetes Mellitus (DM) have increased cardiac risk com-
pared to Non-Diabetics (Non-DM), even after normal myocardial perfusion imaging.
Objective: To evaluate the progression of CAD in diabetics with known or suspected
CAD who received serial MPI.
Methods: The Hartford Hospital database was queried to obtain all patients with known
or suspected CAD with Tc-99m rest/stress myocardial perfusion imaging studies from
1996-2001 (N=9581). DM and Non-DM were evaluated for patients undergoing repeat
studies (DM =217, Non-DM=507), as well as the number converting from normal MPI to
abnormal (fixed and reversible).
Results: Retesting occurred in 16.8% (217/1291) and 9.3% (517/5587) of DM and Non-
DM with normal MPI (p<0.0001). Of those retested, 32.7% (71/217) of DM and 23.4% of
Non-DM (121/517) converted from normal to abnormal (p<0.009). Of all with normal MPI,
5.5% of DM and 2.2% of Non-DM were sent for re-testing and converted to abnormal
(p<0.0001, OR 2.63 {1.93,3.58}. 1.9% of DM and 1.0% of Non-DM (p=0.022, OR 1.80
{1.08, 2.97}) had cardiac death or non-fatal MI and were not included in the analysis of
retesting. The cumulative cardiac death/MI/conversion rates were 7.4% and 3.2% for DM
and Non-DM respectively (p<0.0001, OR 2.4{1.84,3.12}). Inter-test interval was 2.2 ± 1.3
years (p=ns)
Conclusion: CAD progresses more rapidly in patients with diabetes. Symptom based
surveillance is able to identify patients at increased risk.
3:15 p.m.
816-6 Prevalence of Silent Ischemia in Diabetic Patients With 
Subclinical Atherosclerosis: Detection by Stress 
Myocardial Perfusion Imaging
Vijay D. Anand, Susan Fourie, David Hopkins, Patrick Sharp, Avijit Lahiri, Northwick Park 
Hospital, London, United Kingdom, Cardiac Imaging and Research Centre, Wellington 
Hospital, London, United Kingdom
Background: Patients with diabetes mellitus have accelerated atherosclerosis and
increased cardiovascular morbidity and mortality. Hence the detection of significant coro-
nary artery disease before the occurrence of coronary events is desirable in this patient
group.We evaluated the prevalence of silent myocardial ischaemia in asymptomatic dia-
betic patients with moderate to severe subclinical atherosclerosis detected by Electron
Beam Tomography (EBT).
Methods: We prospectively studied 275 asymptomatic patients with type 2 diabetes. 73
patients (26.5%)(mean age +/-SD: 57 +/-7,80% men) with moderate atherosclerotic
plaque burden (coronary calcium score[CCS] >100 Agatston units) were evaluated fur-
ther by Tc99m sestamibi SPECT. We compared the prevalence of silent ischaemia in this
group with a randomly selected control group of asymptomatic non-diabetic patients with
similar cardiovascular risk factor profiles and CCS (n = 77).
Results: Diabetic patients with moderate plaque burden had a higher prevalence (40%
vs 17%, chi square statistic = 4.78, p = 0.029) and extent of myocardial ischaemia(mean
summed stress score [SSS] +/- SD in diabetics: 2.4 +/- 3.8 vs mean SSS in non diabet-
ics: 1+/- 2.5, p = 0.04) in comparison to non-diabetics with the same CCS. The above dif-
ferences were attenuated in patients with a higher plaque burden (CCS>400). 
Conclusion: A lower CCS threshold (CCS>100) may be used to identify asymptomatic
diabetic patients who have silent myocardial ischaemia.
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1112-141 Determinants of Visual 2-D Echo Assessment of Left 
Ventricular Wall Motion: Comparison With Myocardial 
Thickening on Cardiac Magnetic Resonance Imaging
Charles A. Nelson, Jane McCrohon, Stephen Rose, Thomas Marwick, University of 
Queensland, Brisbane, Australia
Background: left ventricular wall motion on 2d echo (2de) is usually scored visually. we
sought to examine the determinants of visually assessed wall motion scoring on 2de by
comparison with myocardial thickening quantified on MRI.
Methods: using a 16 segment model, we studied 287 segments in 30 patients aged 61+/
-11 years (6 female), with ischaemic LV dysfunction (defined by at least 2 segments dys-
functional on 2de). 2de was performed in 5 views and wall motion scores (WMS)
assigned: 1 (normal) 103 segments, 2 (hypokinetic) 93 segments, 3 (akinetic) 87 seg-
ments. MRI was used to measure end systolic wall thickness (ESWT), end diastolic wall
thickness (EDWT) and percentage systolic wall thickening (SWT%) in the plane of the
2de and to assess WMS in the same planes visually. No patient had a clinical ischemic
event between the tests.
Results: visual assessment of wall motion by 2de and MRI showed moderate agreement
(kappa = 0.425). Resting 2de wall motion correlated significantly (p<0.01) with ESWT(-
0.345), EDWT(-0.379) and SWT%(-0.334).
Conclusion: SWT% and ESWT decrease with increasing WMS. However, the distinction
between hypo and akinesis appears to correlate better with ESWT than SWT% or EDWT.
1112-142 Prediction of Right Ventricular Ejection Fraction From 
Doppler Tei Index
Shiro Yoshifuku, Yutaka Otsuji, Koichi Kihara, Masanori Tsurugida, Satoshi Yoshino, 
Shinichi Minagoe, Chuwa Tei, Fujimoto-Hayasuzu Hospital, Miyakonojyo, Japan, 
Kagoshima University School of Medicine, Kagoshima, Japan
Background: Measurement of right ventricular (RV) ejection fraction (EF) is not neces-
sarily feasible due to the complicated geometry. Tei index, defined as the sum of isovolu-
metric contraction and relaxation time (ICT and IRT) divided by ejection time, is a non-
geometric measure of ventricular function, which can be applied to the RV. We hypothe-
sized that RV Tei index has significant correlation with RV EF. Therefore, the purpose of
this study was to evaluate the feasibility of RV Tei index to predict EF. Methods: RV Tei
index by Doppler echocardiography as (a-b)/b, where a is the interval between cessation
and onset of tricuspid flow and b is the pulmonary flow ejection time, and RV ejection
fraction by TC - 99m cardiac pool scintigraphy (first pass method) were measured in 25
patients with clinically suspected RV dysfunction (19 with ischemic heart disease, 2 with
biventricular dysfunction, 2 with interstitial pneumonia, and 2 with mitral stenosis). RV EF
< 40% was defined as reduced RV EF. Results: 1) RV Tei index has good and significant
relation with RV ejection fraction (R = -0.81, P < 0.0001). 2) Diagnosis of reduced RV EF
by Tei index > 0.44 had the sensitivity, specificity, and accuracy of 88%, 94%, and 92%,
respectively. Conclusion: RV Tei index enables simple and feasible prediction of RV
ejection fraction. 
Patient Category Myocardial Perfusion Imaging (MPI)
Abnormal MPI Normal MPI
Non-diabetic (CCS: 100-400) 10(17%) 48(83%)
Diabetic (CCS: 100-400) 14(40%) 21(60%)
Non-diabetic (CCS>400) 8(44%) 10(56%)
Diabetic (CCS>400) 25(66%) 13(34%)
1 (normal) 2 (hypokinetic) 3 (akinetic) p ANOVA p (2 vs 3)
EDWT 9.2±2.4 mm 9.2±2.1 mm 8.4±1.5 mm <0.0001 0.07
ESWT 12.8±3.0 mm 11.3±3.1 mm 9.9±3.2 mm <0.0001 0.003
SWT % 47±41 24±24 21±31 <0.0001 0.481
